Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-11

Clinical Trial Update: Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating tranexamic acid in debridement surgery for burns to assess impact on bleeding and transfusion requirements.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Burns | Phase 3 | Status: UNKNOWN